E

EZZ Life Science Holdings Ltd
ASX:EZZ

Watchlist Manager
EZZ Life Science Holdings Ltd
ASX:EZZ
Watchlist
Price: 3.01 AUD -5.05% Market Closed
Market Cap: 138.9m AUD
Have any thoughts about
EZZ Life Science Holdings Ltd?
Write Note

EZZ Life Science Holdings Ltd
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

EZZ Life Science Holdings Ltd
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Cash
AU$19m
CAGR 3-Years
29%
CAGR 5-Years
115%
CAGR 10-Years
N/A
Anteotech Ltd
ASX:ADO
Cash
AU$5m
CAGR 3-Years
-38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proteomics International Laboratories Ltd
ASX:PIQ
Cash
AU$441.3k
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Cash
AU$10.6m
CAGR 3-Years
-41%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Cash
AU$703k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
3%
Genetic Signatures Ltd
ASX:GSS
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

EZZ Life Science Holdings Ltd
Glance View

Market Cap
133.7m AUD
Industry
Life Sciences Tools & Services

EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.

EZZ Intrinsic Value
5.04 AUD
Undervaluation 40%
Intrinsic Value
Price
E

See Also

What is EZZ Life Science Holdings Ltd's Cash?
Cash
19m AUD

Based on the financial report for Jun 30, 2024, EZZ Life Science Holdings Ltd's Cash amounts to 19m AUD.

What is EZZ Life Science Holdings Ltd's Cash growth rate?
Cash CAGR 5Y
115%

Over the last year, the Cash growth was 38%. The average annual Cash growth rates for EZZ Life Science Holdings Ltd have been 29% over the past three years , 115% over the past five years .

Back to Top